With the burgeoning interest in nanomedicine-based drugs, the pharmacokinetics and pharmacodynamics must be closely evaluated to optimize drug delivery to the target site while minimizing adverse effects since nanoparticles are designed to be long-lasting with minimal excretion within organs.